Market Cap:
24h Vol:
Stocklytics Platform
Asset logo  UNH
UnitedHealth Group
69 / 100

Is UNH a Buy or Sell based on AI Analysis?

Fundamental Analysis

UnitedHealth Group Inc (UNH) has a strong financial position with a market cap of $445.43 billion. The company has a healthy balance sheet with assets of $273.72 billion and a low debt-to-equity ratio of 0.68. Additionally, UNH has a solid return on equity of 24.99%, indicating efficient use of shareholder funds. The company also pays dividends with a dividend yield of 1.54% and a payout ratio of 29.94%, showing a commitment to returning value to shareholders while maintaining financial stability. Furthermore, UnitedHealth Group Inc has shown consistent revenue growth, with a revenue growth rate of 15.36%. The company also has a positive net margin of 6.02% and a strong operating margin of 8.14%, demonstrating efficient cost management and profitability. UNH's strong free cash flow margin of 6.91% and free cash flow of $25.68 billion indicate the company's ability to generate cash and reinvest in growth opportunities. Overall, these fundamental indicators suggest that UnitedHealth Group Inc is a financially stable and well-performing company in the healthcare sector.

Positive Development

UNH's stock outperformed competitors on strong trading days, indicating that investors have confidence in the company's performance. The company was recognized as a top dividend stock, which could attract investors seeking stable returns. UnitedHealth Group Inc. has been mentioned as one of the key players in the healthcare sector, which suggests that the company has a strong market position.

Negative Development

UnitedHealth Group Inc. has been hit by a cyber security attack, which could lead to disruptions in its operations and potential financial losses. The company is undergoing an antitrust investigation, which could lead to legal and regulatory issues. The stock has shown a downward trend over the past week, which could be a sign of investor caution.

Technical Analysis

UnitedHealth Group Inc (UNH) currently has a neutral technical rating, indicating no strong buy or sell signals. The stock price has experienced a significant drop of -8.77% in the past week and is down -4.2% in the one-month period. However, over the five-year timeframe, UNH has shown remarkable growth with a price change percent of 104.09%, showcasing its strong performance and potential for long-term investors. The company's technical indicators are also mixed, with two buy signals and six hold signals for the month, suggesting a cautious approach for traders. Additionally, UNH has a beta value of 0.55, indicating that the stock is less volatile compared to the overall market. The stock's 50-day moving average (SMA) is at -2.13, suggesting a downward trend in the short term. Despite the recent price declines, analysts are quite bullish on UnitedHealth Group, with a majority of 22 out of 30 analysts recommending a buy rating. Moreover, the AI forecast for the stock is currently unavailable, but the analyst forecast price of $577.57 shows a potential upside of 19.9% from the current price of $481.69. Overall, UNH's technical analysis points to a mixed outlook with potential growth opportunities for long-term investors.

Conclusion and recommendation

Based on the data provided, UnitedHealth Group Inc (UNH) appears to be a solid investment opportunity in the healthcare sector. The company has a strong financial standing with a market cap of $445.43 billion and a steady revenue growth of 15.36%. With a dividend yield of 1.54% and a payout ratio of 29.94%, UNH also offers attractive returns to investors. Additionally, the company's return on equity of 24.99% and return on assets of 7.79% indicate efficient use of resources and profitability. Furthermore, UNH has a strong market score, industry score, and sector score, pointing towards its leadership position in the market. In conclusion, UnitedHealth Group Inc is a recommended buy for investors looking for a stable and profitable investment in the healthcare sector. With a strong financial performance, consistent revenue growth, and positive analyst recommendations, UNH is poised for long-term growth and value creation. The company's impressive dividend yield, solid market standing, and efficient operational metrics make it a top choice for investors seeking a reliable and profitable investment opportunity in the healthcare industry.

Data refers to:February 28, 2024
or to generate AI stock Analysis for UnitedHealth Group (Powered by our data and Chat GPT 4).
This AI-generated analysis is provided for informational purposes only and should not be considered as investment advice. The analysis is an experimental feature, and the information contained herein is derived from various sources and AI algorithms, which may not be entirely accurate or complete. Investors should conduct their own research and consult with a financial advisor before making any investment decisions. The author and the platform providing this analysis assume no responsibility for any losses or damages resulting from the use of this analysis or the information contained within.
About AI-Powered Analysis
Powered by the advanced GPT-4 engine developed by OpenAI, a leading organization in artificial intelligence research, our AI-conducted stock analysis provides a comprehensive and actionable view of the stock market. This approach covers both technical and fundamental aspects, integrating relevant news developments, analysts' price targets, and predictions for upcoming trading periods into a clear and concise summary. This ensures a rounded perspective on a stock's performance and its potential, enhancing the understanding and the decision-making process for investors.
Share your feedback

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level